Summit Global Investments’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.7M | Buy |
60,350
+18,119
| +43% | +$482K | 0.1% | 108 |
|
|
2025
Q4 | $1.05M | Buy |
+42,231
| New | +$1.06M | 0.06% | 190 |
|
|
2025
Q1 | – | Sell |
-13,260
| Closed | -$352K | – | 546 |
|
|
2024
Q4 | $352K | Sell |
13,260
-1,531
| -10% | -$41.5K | 0.02% | 423 |
|
|
2024
Q3 | $428K | Buy |
14,791
+281
| +2% | +$8.2K | 0.03% | 382 |
|
|
2024
Q2 | $406K | Sell |
14,510
-33,985
| -70% | -$936K | 0.03% | 380 |
|
|
2024
Q1 | $1.35M | Sell |
48,495
-45,281
| -48% | -$1.26M | 0.1% | 163 |
|
|
2023
Q4 | $2.7M | Buy |
93,776
+3,348
| +4% | +$101K | 0.18% | 104 |
|
|
2023
Q3 | $3M | Sell |
90,428
-123,152
| -58% | -$4.35M | 0.2% | 102 |
|
|
2023
Q2 | $7.83M | Sell |
213,580
-123,392
| -37% | -$4.8M | 0.52% | 49 |
|
|
2023
Q1 | $13.7M | Buy |
336,972
+2,305
| +0.7% | +$99.6K | 1.06% | 19 |
|
|
2022
Q4 | $17.1M | Sell |
334,667
-17,524
| -5% | -$840K | 1.45% | 13 |
|
|
2022
Q3 | $15.4M | Sell |
352,191
-16,792
| -5% | -$816K | 1.43% | 13 |
|
|
2022
Q2 | $19.3M | Sell |
368,983
-52,549
| -12% | -$2.68M | 1.7% | 7 |
|
|
2022
Q1 | $21.8M | Buy |
421,532
+248,130
| +143% | +$12.9M | 1.61% | 6 |
|
|
2021
Q4 | $10.2M | Buy |
173,402
+15,225
| +10% | +$754K | 0.66% | 36 |
|
|
2021
Q3 | $6.8M | Buy |
158,177
+66,611
| +73% | +$2.95M | 0.51% | 49 |
|
|
2021
Q2 | $3.58M | Buy |
+91,566
| New | +$3.56M | 0.21% | 91 |
|
|
2021
Q1 | – | Sell |
-5,600
| Closed | -$206K | – | 569 |
|
|
2020
Q4 | $206K | Sell |
5,600
-71,185
| -93% | -$2.61M | 0.02% | 250 |
|
|
2020
Q3 | $2.67M | Buy |
76,785
+557
| +0.7% | +$19.5K | 0.28% | 61 |
|
|
2020
Q2 | $2.37M | Buy |
76,228
+5,326
| +8% | +$181K | 0.27% | 60 |
|
|
2020
Q1 | $2.2M | Buy |
70,902
+43,641
| +160% | +$1.49M | 0.32% | 54 |
|
|
2019
Q4 | $1.01M | Buy |
27,261
+1,934
| +8% | +$68.9K | 0.11% | 114 |
|
|
2019
Q3 | $863K | Buy |
25,327
+2,296
| +10% | +$83.5K | 0.1% | 156 |
|
|
2019
Q2 | $947K | Buy |
+23,031
| New | +$915K | 0.12% | 118 |
|
|
2018
Q4 | – | Sell |
-5,029
| Closed | -$210K | – | 299 |
|
|
2018
Q3 | $210K | Sell |
5,029
-1,509
| -23% | -$58.1K | 0.03% | 246 |
|
|
2018
Q2 | $225K | Sell |
6,538
-214,829
| -97% | -$7.34M | 0.03% | 247 |
|
|
2018
Q1 | $7.45M | Sell |
221,367
-10,482
| -5% | -$360K | 1.19% | 28 |
|
|
2017
Q4 | $7.97M | Sell |
231,849
-196,874
| -46% | -$6.71M | 1.23% | 32 |
|
|
2017
Q3 | $14.5M | Buy |
428,723
+217,937
| +103% | +$7M | 2.27% | 4 |
|
|
2017
Q2 | $6.72M | Buy |
210,786
+46,885
| +29% | +$1.48M | 2.01% | 4 |
|
|
2017
Q1 | $5.32M | Buy |
163,901
+26,837
| +20% | +$846K | 1.73% | 13 |
|
|
2016
Q4 | $4.22M | Buy |
+137,064
| New | +$4.18M | 1.53% | 20 |
|
Other funds holding PFE
VCM
VPM
Summit Global Investments's PFE Position: Q1 2026 in Review
Summit Global Investments increased its Pfizer (PFE) stake by 43% in Q1 2026, buying an estimated $482K and bringing the position to 60,350 shares worth $1.7M. The position accounts for 0.1% of the portfolio, ranked #108.
Summit Global Investments first reported a position in PFE in Q4 2016 and has held it in 32 quarters since. The position peaked at $21.8M in Q1 2022. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Summit Global Investments held 60,350 shares of Pfizer worth $1.7M as of Q1 2026.
- Summit Global Investments bought 18,119 Pfizer shares in Q1 2026, an estimated $482K.
- Pfizer made up 0.1% of Summit Global Investments's portfolio in Q1 2026, its #108 holding.
- Summit Global Investments first reported a position in Pfizer in Q4 2016 and has held it in 32 quarters since.
- Summit Global Investments's Pfizer position peaked at $21.8M in Q1 2022.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Summit Global Investments's 13F filing for Q1 2026, filed 7 May 2026.